None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ? An adult patient aged 20-80 years who underwent mastoidectomy and tympanoplasty with chronic otitis media (including chronic otitis media with cholesteatoma) ? Patient with bone conduction hearing threshold of 25dB or higher and mean air-bone gap of 25dB or higher in mixed hearing loss ear, air conduction threshold of 45dB or higher in other side ? Patient with PBmax over 50% in speech audiometry ? Difficult to expect hearing improvement with ossiculoplasty ? Patient who do not get enough gain in wearing a general hearing aid or difficult to wear a hearing aid because of otorrhea or change in the shape of the external auditory canal ? No contraindication to general anesthesia ? Patient who agrees to participate in the clinical study and have signed a written consent form him/herself
Exclusion criteria
Exclusion criteria: ? Those who are illiterate or unable to read the written consent of a foreigner or have difficulty understanding the clinical trial due to mental retardation ? Patients who do not have residual hearing or whose speech discrimination score is less than 50% are not expected to have hearing improvement even after middle ear implantation ? Patients who do not have residual hearing and who are indication for cochlear implants ? Patients who are expeected to impreve hearing even by using hearing aids ? Patients with suspected anomalies of inner ear and cochlear nerve pathway and requiring other method of treatment ? Patients judged to be inappropriate for this clinical trial by the judgement of the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| APHAB(Abbreviated Profile of Hearing Aid Benefit), K-IOI-HA(Korean version of International Outcome Inventory for Hearing Aids) questionnaire | — |
Secondary
| Measure | Time frame |
|---|---|
| Pure tone audiometry;Speech audiometry | — |
Countries
Korea, Republic of
Contacts
Asan Medical Center